Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing, Proceedings of the National Academy of Sciences, vol.107, issue.28, pp.12629-12662, 2010. ,
DOI : 10.1101/gr.078212.108
Hallmarks of Cancer: The Next Generation. Cell, pp.646-74, 2011. ,
La régulation du cycle cellulaire. [internet] ,
DNA related to the transforming gene(s) of avian sarcoma viruses is present in normal avian DNA, Nature, vol.3, issue.5547, pp.170-173, 1976. ,
DOI : 10.1016/0005-2787(73)90095-6
Mutation and Cancer: Statistical Study of Retinoblastoma, Proceedings of the National Academy of Sciences, vol.68, issue.4, pp.820-823, 1971. ,
DOI : 10.1073/pnas.68.4.820
Survie des personnes atteintes de cancer en France métropolitaine, 1989. ,
DOI : 10.1016/j.respe.2016.06.084
Risk determination and prevention of breast cancer, Breast Cancer Research, vol.4, issue.62, p.446, 2014. ,
DOI : 10.1126/scitranslmed.3003218
Priorities for the primary prevention of breast cancer, CA: A Cancer Journal for Clinicians, vol.87, issue.6, pp.186-94 ,
DOI : 10.2105/AJPH.87.10.1603
The fraction of cancer attributable to lifestyle and environmental factors in the UK in 2010, Br J Cancer, vol.16105, issue.2, pp.77-81, 2011. ,
Physical activity and breast cancer prevention. Recent Results Cancer Res Fortschritte Krebsforsch Progres Dans Rech Sur Cancer, pp.13-42, 2011. ,
Moderate Alcohol Consumption During Adult Life, Drinking Patterns, and Breast Cancer Risk, JAMA, vol.306, issue.17, pp.1884-90, 2011. ,
DOI : 10.1001/jama.2011.1590
Physical activity, diet, adiposity and female breast cancer prognosis: A review of the epidemiologic literature, Maturitas, vol.66, issue.1, pp.5-15, 2010. ,
DOI : 10.1016/j.maturitas.2010.01.004
Radiation Effects on Breast Cancer Risk: A Pooled Analysis of Eight Cohorts, Radiation Research, vol.158, issue.2, 2002. ,
DOI : 10.1667/0033-7587(2002)158[0220:REOBCR]2.0.CO;2
Epidemiology of breast cancer, The Lancet Oncology, vol.2, issue.3, pp.133-173, 2001. ,
DOI : 10.1016/S1470-2045(00)00254-0
ABC of breast diseases: Breast cancer---epidemiology, risk factors, and genetics, BMJ, vol.321, issue.7261, pp.624-632, 2000. ,
DOI : 10.1136/bmj.321.7261.624
Breast cancer occurred after Hodgkin's disease: Clinico-pathological features, treatments and outcome: Analysis of 214 cases, Critical Reviews in Oncology/Hematology, vol.81, issue.1, pp.29-37 ,
DOI : 10.1016/j.critrevonc.2011.01.005
Epidemiology and Prevention of Breast Cancer, Annual Review of Public Health, vol.17, issue.1, pp.47-67, 1996. ,
DOI : 10.1146/annurev.pu.17.050196.000403
Benign Breast Disease and the Risk of Breast Cancer, New England Journal of Medicine, vol.353, issue.3, pp.229-266, 2005. ,
DOI : 10.1056/NEJMoa044383
Estrogen Carcinogenesis in Breast Cancer, New England Journal of Medicine, vol.354, issue.3, pp.270-82, 2006. ,
DOI : 10.1056/NEJMra050776
Food, nutrition, and the prevention of cancer: a global perspective American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. ,
The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer, Journal of Clinical Epidemiology, vol.42, issue.10, pp.963-73, 1989. ,
DOI : 10.1016/0895-4356(89)90161-3
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial, JAMA Jul, vol.17288, issue.3, pp.321-354, 2002. ,
Breast cancer and hormone-replacement therapy: the Million Women Study, The Lancet, vol.362, issue.9392, pp.419-446, 2003. ,
DOI : 10.1016/S0140-6736(03)14596-5
Family history and the risk of breast cancer: A systematic review and meta-analysis, International Journal of Cancer, vol.48, issue.5, pp.800-809, 1997. ,
DOI : 10.1038/bjc.1990.23
New Malignancies Among Cancer Survivors: SEER Cancer Registries, National Cancer Institute. NIH Publ, pp.5-5302, 1973. ,
Hormone therapy and ovarian cancer, JAMA. Jul, vol.15302, issue.3, pp.298-305, 2009. ,
Menopausal hormone use and ovarian cancer risk: individual participant meta-analysis of 52 epidemiological studies, Lancet Lond Engl, vol.385, issue.9980, pp.1835-1877, 2009. ,
Occupational exposure to asbestos and ovarian cancer: a meta-analysis. Environ Health Perspect, pp.1211-1218, 2011. ,
DOI : 10.1289/ehp.1003283
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230399/pdf
Height, body mass index, and ovarian cancer: a pooled analysis of 12 cohort studies. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol, pp.902-914, 2008. ,
BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing -US Preventive Services Task Force. [internet] [cited Available from: https://www.uspreventiveservicestaskforce.org/Page/Document/RecommendationSt atementFinal/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic- testing, 2017. ,
Cancer genetics: estimation of the needs of the population in France for the next ten years], Bull Cancer, vol.96, issue.9, pp.875-900, 2009. ,
BRCA1 testing should be offered to individuals with triple-negative breast cancer diagnosed below 50 years, British Journal of Cancer, vol.21, issue.6, pp.1234-1242, 2012. ,
DOI : 10.1186/1471-2407-9-86
URL : http://doi.org/10.1038/bjc.2012.31
Gene analysis techniques and susceptibility gene discovery in??non-BRCA1/BRCA2 familial breast cancer, Surgical Oncology, vol.24, issue.2, pp.100-109 ,
DOI : 10.1016/j.suronc.2015.04.003
Linkage of early-onset familial breast cancer to chromosome 17q21, Science, vol.250, issue.4988, pp.1684-1693, 1990. ,
DOI : 10.1126/science.2270482
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science, pp.66-71, 1994. ,
Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. Science, pp.2088-90, 1994. ,
Human, canine and murine BRCA1 genes: sequence comparison among species, Human Molecular Genetics, vol.5, issue.9, pp.1289-98, 1996. ,
DOI : 10.1093/hmg/5.9.1289
URL : https://academic.oup.com/hmg/article-pdf/5/9/1289/1661461/5-9-1289.pdf
Functional communication between endogenous BRCA1 and its partner, BARD1, during Xenopus laevis development, Proceedings of the National Academy of Sciences, vol.36, issue.1, pp.12078-83, 2001. ,
DOI : 10.1016/S0091-679X(08)60270-8
URL : http://www.pnas.org/content/98/21/12078.full.pdf
Insights into the functions of BRCA1 and BRCA2, Trends in Genetics, vol.16, issue.2, pp.69-74, 2000. ,
DOI : 10.1016/S0168-9525(99)01930-7
BRCA1 protein is linked to the RNA polymerase II holoenzyme complex via RNA helicase A, Nat Genet, 1998. ,
Molecular views of recombination proteins and their control, Nature Reviews Molecular Cell Biology, vol.4, issue.6, pp.435-480, 2003. ,
DOI : 10.1038/nrm1127
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies, The American Journal of Human Genetics, vol.72, issue.5, pp.1117-1147, 2003. ,
DOI : 10.1086/375033
Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: A Systematic Review to Update the U.S. Preventive Services Task Force Recommendation, Agency for Healthcare Research and Quality (US), 2013. ,
DOI : 10.7326/M13-1684
Tumour biological features of BRCA1-induced breast and ovarian cancer, European Journal of Cancer, vol.33, issue.3, pp.362-71, 1990. ,
DOI : 10.1016/S0959-8049(97)89007-7
Pathology of Ovarian Cancers in BRCA1 and BRCA2 Carriers. Clin Cancer Res, pp.2473-81, 2004. ,
Sensitivity and predictive value of criteria for p53germline mutation screening, Journal of Medical Genetics, vol.38, issue.1, pp.43-50, 2001. ,
DOI : 10.1136/jmg.38.1.43
Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype, Cancer Res, vol.63, issue.20, pp.6643-50, 2003. ,
LKB1-Dependent Signaling Pathways, Annual Review of Biochemistry, vol.75, issue.1, pp.137-63, 2006. ,
DOI : 10.1146/annurev.biochem.75.103004.142702
Peutz-Jeghers syndrome, The American Journal of Gastroenterology, vol.34, issue.3, 1266. ,
DOI : 10.1210/jc.83.8.2972
Solution structure of the epithelial cadherin domain responsible for selective cell adhesion, Science, vol.4, issue.6, 1995. ,
DOI : 10.1007/BF00398413
The Biology of Cancer. Garland Science, 2006. ,
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers, EMBO J, vol.14, issue.24, pp.6107-6122, 1995. ,
Ten genes for inherited breast cancer. Cancer Cell, Feb, vol.11, issue.2, pp.103-108, 2007. ,
DOI : 10.1016/j.ccr.2007.01.010
URL : https://doi.org/10.1016/j.ccr.2007.01.010
DNA double-strand breaks: signaling, repair and the cancer connection, Nature Genetics, vol.27, issue.3, pp.247-54, 2001. ,
DOI : 10.1038/85798
Mre11???Rad50???Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signaling, and the chromatin templateThis paper is one of a selection of papers published in this Special Issue, entitled 28th International West Coast Chromatin and Chromosome Conference, and has undergone the Journal's usual peer review process., Biochemistry and Cell Biology, vol.4, issue.4, pp.509-529, 2007. ,
DOI : 10.1016/S0960-9822(01)00019-7
Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, pp.421-430, 2003. ,
DOI : 10.1016/s1535-6108(03)00110-7
URL : https://doi.org/10.1016/s1535-6108(03)00110-7
Proteintruncating variants in moderate-risk breast cancer susceptibility genes: a metaanalysis of high-risk case-control screening studies, Cancer Genet, 2015. ,
Control of BRCA2 Cellular and Clinical Functions by a Nuclear Partner, PALB2, Molecular Cell, vol.22, issue.6, pp.719-748, 2006. ,
DOI : 10.1016/j.molcel.2006.05.022
Cooperation of breast cancer proteins PALB2 and piccolo BRCA2 in stimulating homologous recombination, Nature Structural & Molecular Biology, vol.269, issue.10, pp.1247-54, 2010. ,
DOI : 10.1016/S0921-8777(97)00028-1
Enhancement of RAD51 recombinase activity by the tumor suppressor PALB2, Nat Struct Mol Biol, 2010. ,
BACH1, a Novel Helicase-like Protein, Interacts Directly with BRCA1 and Contributes to Its DNA Repair Function, Cell, vol.105, issue.1, pp.149-60, 2001. ,
DOI : 10.1016/S0092-8674(01)00304-X
Truncating mutations in the Fanconi anemia J gene BRIP1 are low-penetrance breast cancer susceptibility alleles, Nature Genetics, vol.42, issue.11, pp.1239-1280, 2006. ,
DOI : 10.1136/jmg.2004.022673
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer, JNCI: Journal of the National Cancer Institute, vol.107, issue.11, 2015. ,
DOI : 10.1093/jnci/djv214
Rad50 Adenylate Kinase Activity Regulates DNA Tethering by Mre11/Rad50 Complexes, Molecular Cell, vol.25, issue.5, pp.647-61, 2007. ,
DOI : 10.1016/j.molcel.2007.01.028
URL : https://doi.org/10.1016/j.molcel.2007.01.028
DNA end-binding specificity of human Rad50/Mre11 is influenced by ATP, Nucleic Acids Research, vol.30, issue.20, pp.4425-4456, 2002. ,
DOI : 10.1093/nar/gkf574
Le concept de cible en cancérologie. Thérapie ciblée des cancers, 2009. ,
Role of Mre11 in chromosomal nonhomologous end joining in mammalian cells, Nature Structural & Molecular Biology, vol.24, issue.8, pp.819-843, 2009. ,
DOI : 10.1128/MCB.16.5.2164
URL : https://hal.archives-ouvertes.fr/hal-00413788
The complex genetic landscape of familial breast cancer, Human Genetics, vol.134, issue.3, pp.845-63, 2013. ,
DOI : 10.1007/s10549-012-2141-2
Cowden Syndrome: A Critical Review of the Clinical Literature, Journal of Genetic Counseling, vol.69, issue.4, pp.13-27, 2009. ,
DOI : 10.3171/foc.2006.20.1.7
Cowden syndrome. Semin Oncol, pp.428-462, 2007. ,
Will the real Cowden syndrome please stand up: revised diagnostic criteria, Journal of Medical Genetics, vol.37, issue.11, pp.828-858, 2000. ,
DOI : 10.1136/jmg.37.11.828
URL : http://jmg.bmj.com/content/jmedgenet/37/11/828.full.pdf
Cowden's Disease, Annals of Internal Medicine, vol.58, issue.1, pp.136-178, 1963. ,
DOI : 10.7326/0003-4819-58-1-136
Localization of the gene for Cowden disease to chromosome 10q22???23, Nature Genetics, vol.53, issue.1, pp.114-120, 1996. ,
DOI : 10.1016/0092-8674(91)90189-6
Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease, Human Molecular Genetics, vol.6, issue.8, pp.1383-1390, 1997. ,
DOI : 10.1093/hmg/6.8.1383
Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation, Human Molecular Genetics, vol.7, issue.3, pp.507-522, 1998. ,
DOI : 10.1093/hmg/7.3.507
Nuclear-Cytoplasmic Partitioning of Phosphatase and Tensin Homologue Deleted on Chromosome 10 (PTEN) Differentially Regulates the Cell Cycle and Apoptosis, Cancer Research, vol.65, issue.18, pp.8096-100, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-1888
Crystal Structure of the PTEN Tumor Suppressor, Cell, vol.99, issue.3, pp.323-357, 1999. ,
DOI : 10.1016/S0092-8674(00)81663-3
PTEN induces apoptosis and cell cycle arrest through phosphoinositol-3-kinase/Akt-dependent and -independent pathways, Human Molecular Genetics, vol.10, issue.3, pp.237-279, 2001. ,
DOI : 10.1093/hmg/10.3.237
URL : https://academic.oup.com/hmg/article-pdf/10/3/237/9464146/dde021.pdf
PTEN function: how normal cells control it and tumour cells lose it, Biochemical Journal, vol.382, issue.1, pp.1-11, 2004. ,
DOI : 10.1042/BJ20040825
Adenoviral-mediated expression of MMAC/PTEN inhibits proliferation and metastasis of human prostate cancer cells, Clin Cancer Res Off J Am Assoc Cancer Res, vol.8, issue.6, pp.1904-1918, 2002. ,
Genetic deletion of the Pten tumor suppressor gene promotes cell motility by activation of Rac1 and Cdc42 GTPases, Current Biology, vol.10, issue.7, pp.401-405, 2000. ,
DOI : 10.1016/S0960-9822(00)00417-6
Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN, Cell, vol.95, issue.1, pp.29-39, 1998. ,
DOI : 10.1016/S0092-8674(00)81780-8
The PTEN tumor suppressor protein: an antagonist of phosphoinositide 3-kinase signaling, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, vol.1470, issue.1, pp.21-35, 2000. ,
DOI : 10.1016/S0304-419X(99)00032-3
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems, Proceedings of the National Academy of Sciences, vol.8, issue.21, pp.1563-1571, 1999. ,
DOI : 10.1016/S0960-9822(07)00488-5
Cowden disease: a review, International Journal of Clinical Practice, vol.29, issue.1904-14, pp.645-52, 2007. ,
DOI : 10.1111/j.1524-4725.1989.tb03122.x
The biology and clinical relevance of the PTEN tumor suppressor pathway, J Clin Oncol Off J Am Soc Clin Oncol Jul, vol.1522, issue.14, pp.2954-63, 2004. ,
Genetic Predisposition to Cancer: The Consequences of a Delayed Diagnosis of Gorlin Syndrome, Clinical Oncology, vol.17, issue.8, pp.650-654, 2005. ,
DOI : 10.1016/j.clon.2005.07.014
Fitzpatrick's Dermatology in General Medicine, 2008. ,
Skelettale und kutane Charakteristika des n??voiden Basalzellkarzinomsyndroms (Gorlin-Goltz-Syndrom), R??Fo - Fortschritte auf dem Gebiet der R??ntgenstrahlen und der bildgebenden Verfahren, vol.179, issue.6, pp.618-644, 2007. ,
DOI : 10.1055/s-2007-963117
URL : http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-2007-963117.pdf
Nevoid basal cell carcinoma (Gorlin) syndrome, Genet Med Off J Am Coll Med Genet, vol.6, issue.6, pp.530-539, 2004. ,
DOI : 10.1038/npg.els.0006082
Nevoid basal cell carcinoma syndrome (Gorlin syndrome), Orphanet Journal of Rare Diseases, vol.3, issue.1, p.32, 2008. ,
DOI : 10.1186/1750-1172-3-32
Clinical manifestations in 105 persons with nevoid basal cell carcinoma syndrome, American Journal of Medical Genetics, vol.22, issue.3, pp.299-308, 1997. ,
DOI : 10.1001/archderm.1959.01560130069008
Intracranial calcifications in childhood medulloblastoma: relation to nevoid basal cell carcinoma syndrome, AJNR Am J Neuroradiol, vol.21, issue.4, pp.790-794, 2000. ,
Early recognition of basal cell naevus syndrome, European Journal of Pediatrics, vol.73, issue.3, pp.126-156, 2005. ,
DOI : 10.1007/s00431-004-1597-4
Location of gene for Gorlin syndrome. The Lancet, pp.581-583, 1992. ,
Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome, Cell, vol.85, issue.6, pp.841-51, 1996. ,
DOI : 10.1016/S0092-8674(00)81268-4
Human Homolog of patched, a Candidate Gene for the Basal Cell Nevus Syndrome, Science, vol.272, issue.5268, pp.1668-71, 1996. ,
DOI : 10.1126/science.272.5268.1668
The hedgehog pathway and basal cell carcinomas, Human Molecular Genetics, vol.10, issue.7, pp.757-62, 2001. ,
DOI : 10.1093/hmg/10.7.757
Spectrum of PTCH1 Mutations in French Patients with Gorlin Syndrome, Journal of Investigative Dermatology, vol.121, issue.3, pp.478-81, 2003. ,
DOI : 10.1046/j.1523-1747.2003.12423.x
PTCH mutations: distribution and analyses, Human Mutation, vol.57, issue.3, pp.215-224, 2006. ,
DOI : 10.1002/humu.20296
Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident, Am J Hum Genet, vol.60, issue.1, pp.21-27, 1997. ,
First evidence of genotype???phenotype correlations in Gorlin syndrome, Journal of Medical Genetics, vol.21, issue.4 Suppl, 2017. ,
DOI : 10.1136/jmedgenet-2017-104669
Mutations in SUFU predispose to medulloblastoma, Nature Genetics, vol.9, issue.3, pp.306-316, 2002. ,
DOI : 10.1016/S0960-9822(99)80482-5
Identification of a SUFU germline mutation in a family with Gorlin syndrome, Am J Med Genet A, vol.149, issue.7, pp.1539-1582, 2009. ,
Genetic Elimination of Suppressor of Fused Reveals an Essential Repressor Function in the Mammalian Hedgehog Signaling Pathway, Developmental Cell, vol.10, issue.2, pp.187-97, 2006. ,
DOI : 10.1016/j.devcel.2005.12.013
Estimation des risques tumoraux dans le syndrome de Lynch : résultats de l'étude française ERISCAM. Rev DÉpidémiologie Santé Publique, p.71, 2010. ,
DOI : 10.1016/j.respe.2010.06.080
Cancer du colon héréditaire non polyposique (Syndrome HNPCC). Orphanet, 2004. ,
Cancer colorectal : modalités de dépistage et de prévention chez les sujets à risque élevé et très élevé Recommandation de bonne pratique, 2017. ,
Biochemistry and genetics of eukaryotic mismatch repair., Genes & Development, vol.10, issue.12, pp.1433-1475, 1996. ,
DOI : 10.1101/gad.10.12.1433
URL : http://genesdev.cshlp.org/content/10/12/1433.full.pdf
Fidelity Mechanisms in DNA Replication, Annual Review of Biochemistry, vol.60, issue.1, pp.477-511, 1991. ,
DOI : 10.1146/annurev.bi.60.070191.002401
The human mutator gene homolog MSH2 and its association with hereditary nonpolyposis colon cancer. Cell, pp.1027-1065, 1993. ,
Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer, Nature, issue.6468, pp.368258-61, 1994. ,
Germline mutation of MSH6 as the cause of hereditary nonpolyposis colorectal cancer, Nature Genetics, vol.268, issue.3, pp.271-273, 1997. ,
DOI : 10.1038/382499a0
Mutations of two P/WS homologues in hereditary nonpolyposis colon cancer, Nature, vol.371, issue.6492, pp.75-80, 1994. ,
DOI : 10.1038/371075a0
constitute a distinct class of mutations predisposing to Lynch syndrome, Human Mutation, vol.5, issue.2, pp.197-203, 2009. ,
DOI : 10.3748/wjg.v12.i8.1192
Projecting Individualized Probabilities of Developing Breast Cancer for White Females Who Are Being Examined Annually, JNCI Journal of the National Cancer Institute, vol.81, issue.24, pp.1879-86, 1989. ,
DOI : 10.1093/jnci/81.24.1879
Determining Carrier Probabilities for Breast Cancer???Susceptibility Genes BRCA1 and BRCA2, The American Journal of Human Genetics, vol.62, issue.1, pp.145-58, 1998. ,
DOI : 10.1086/301670
URL : https://doi.org/10.1086/301670
BOADICEA breast cancer risk prediction model: updates to cancer incidences, tumour pathology and web interface, British Journal of Cancer, vol.91, issue.2, pp.535-580, 2014. ,
DOI : 10.1186/bcr2118
URL : http://www.nature.com/bjc/journal/v110/n2/pdf/bjc2013730a.pdf
Identification et prise en charge des prédispositions héréditaires aux cancers du sein et de l'ovaire (mise à jour, Bull Cancer, vol.91, issue.3, pp.219-256, 2004. ,
DOI : 10.1016/j.patbio.2006.02.002
A new scoring system for the chances of identifying a BRCA1/2 mutation outperforms existing models including BRCAPRO, Journal of Medical Genetics, vol.41, issue.6, pp.474-80, 2004. ,
DOI : 10.1136/jmg.2003.017996
Update on the Manchester Scoring System for BRCA1 and BRCA2 testing, Journal of Medical Genetics, vol.42, issue.7, p.39, 2005. ,
DOI : 10.1136/jmg.2005.031989
The Ensembl Variant Effect Predictor, Genome Biology, vol.42, issue.8, p.122, 2016. ,
DOI : 10.1093/nar/gku1206
CNV-seq, a new method to detect copy number variation using high-throughput sequencing, BMC Bioinformatics, vol.10, issue.1, p.80, 2009. ,
DOI : 10.1186/1471-2105-10-80
Available from: https, Variant Effect Predictor. [Internet], 2017. ,
Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology, Genet Med Off J Am Coll Med Genet, 2015. ,
Associations Between Cancer Predisposition Testing Panel Genes and Breast Cancer, JAMA Oncology, vol.3, issue.9, pp.1190-1196, 2017. ,
DOI : 10.1001/jamaoncol.2017.0424
The Breast Cancer Susceptibility Mutation PALB2 1592delT Is Associated with an Aggressive Tumor Phenotype, Clinical Cancer Research, vol.15, issue.9, pp.3214-3236, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-3128
Double PALB2 and BRCA1/BRCA2 mutation carriers are rare in breast cancer and breast-ovarian cancer syndrome families from the French Canadian founder population, Oncology Letters, vol.9, issue.6, p.2015 ,
DOI : 10.3892/ol.2015.3123
Two PALB2 germline mutations found in both BRCA1+ and BRCAx familial breast cancer, Breast Cancer Research and Treatment, vol.490, issue.R1, pp.219-243 ,
DOI : 10.1038/nature11412
ATM mutations in hereditary pancreatic cancer patients. Cancer Discov, pp.41-47, 2012. ,
Mutation Carriers, New England Journal of Medicine, vol.361, issue.2, pp.123-157, 2009. ,
DOI : 10.1056/NEJMoa0900212